Reports

Industry Research Reports

Global Pharmacokinetic Research Service Market Research Report 2025

Global Pharmacokinetic Research Service Market Research Report 2025

Industry: Service & Software

Published Date: 2025-03-11

Pages: 98 Pages

Report ld: 4638136

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Pharmacokinetic Research Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Pharmacokinetic Research Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmacokinetic Research Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Pharmacokinetic Research Service in Pharmaceutical Industry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pharmacokinetic Research Service include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences, Allucent, Admescope, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pharmacokinetic Research Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetic Research Service.

The Pharmacokinetic Research Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacokinetic Research Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacokinetic Research Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

  • Eurofins
  • PPD
  • LabCorp
  • Charles River
  • BioPharma Services
  • Biotrial
  • QPS Holdings
  • Altasciences
  • Allucent
  • Admescope
  • CTI
  • WuXi AppTec
  • GenScript
  • Wuxi Biologics
  • Medicilon
  • Pharmaron
  • Frontage
  • Shanghai Model

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other

Segment by Application

  • Pharmaceutical Industry
  • Government and Ministry of Health
  • Agriculture and Chemical Industry
  • University

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 3: Detailed analysis of Pharmacokinetic Research Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

marn_i1

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmacokinetic Research Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 In Vitro and Radioactive ADME

1.2.3 In Vivo PK and PD

1.2.4 New Drugs and New Molecules

1.2.5 Other

1.3 Market by Application

1.3.1 Global Pharmacokinetic Research Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Industry

1.3.3 Government and Ministry of Health

1.3.4 Agriculture and Chemical Industry

1.3.5 University

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Pharmacokinetic Research Service Market Perspective (2020-2031)

2.2 Global Pharmacokinetic Research Service Growth Trends by Region

2.2.1 Global Pharmacokinetic Research Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmacokinetic Research Service Historic Market Size by Region (2020-2025)

2.2.3 Pharmacokinetic Research Service Forecasted Market Size by Region (2026-2031)

2.3 Pharmacokinetic Research Service Market Dynamics

2.3.1 Pharmacokinetic Research Service Industry Trends

2.3.2 Pharmacokinetic Research Service Market Drivers

2.3.3 Pharmacokinetic Research Service Market Challenges

2.3.4 Pharmacokinetic Research Service Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Pharmacokinetic Research Service Players by Revenue

3.1.1 Global Top Pharmacokinetic Research Service Players by Revenue (2020-2025)

3.1.2 Global Pharmacokinetic Research Service Revenue Market Share by Players (2020-2025)

3.2 Global Pharmacokinetic Research Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmacokinetic Research Service Revenue

3.4 Global Pharmacokinetic Research Service Market Concentration Ratio

3.4.1 Global Pharmacokinetic Research Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetic Research Service Revenue in 2024

3.5 Global Key Players of Pharmacokinetic Research Service Head office and Area Served

3.6 Global Key Players of Pharmacokinetic Research Service, Product and Application

3.7 Global Key Players of Pharmacokinetic Research Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

muLu

4 Pharmacokinetic Research Service Breakdown Data by Type

4.1 Global Pharmacokinetic Research Service Historic Market Size by Type (2020-2025)

4.2 Global Pharmacokinetic Research Service Forecasted Market Size by Type (2026-2031)

muLu

5 Pharmacokinetic Research Service Breakdown Data by Application

5.1 Global Pharmacokinetic Research Service Historic Market Size by Application (2020-2025)

5.2 Global Pharmacokinetic Research Service Forecasted Market Size by Application (2026-2031)

muLu

6 North America

6.1 North America Pharmacokinetic Research Service Market Size (2020-2031)

6.2 North America Pharmacokinetic Research Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmacokinetic Research Service Market Size by Country (2020-2025)

6.4 North America Pharmacokinetic Research Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Pharmacokinetic Research Service Market Size (2020-2031)

7.2 Europe Pharmacokinetic Research Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmacokinetic Research Service Market Size by Country (2020-2025)

7.4 Europe Pharmacokinetic Research Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

muLu

8 Asia-Pacific

8.1 Asia-Pacific Pharmacokinetic Research Service Market Size (2020-2031)

8.2 Asia-Pacific Pharmacokinetic Research Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

muLu

9 Latin America

9.1 Latin America Pharmacokinetic Research Service Market Size (2020-2031)

9.2 Latin America Pharmacokinetic Research Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmacokinetic Research Service Market Size by Country (2020-2025)

9.4 Latin America Pharmacokinetic Research Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Pharmacokinetic Research Service Market Size (2020-2031)

10.2 Middle East & Africa Pharmacokinetic Research Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 Eurofins

11.1.1 Eurofins Company Details

11.1.2 Eurofins Business Overview

11.1.3 Eurofins Pharmacokinetic Research Service Introduction

11.1.4 Eurofins Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.1.5 Eurofins Recent Development

11.2 PPD

11.2.1 PPD Company Details

11.2.2 PPD Business Overview

11.2.3 PPD Pharmacokinetic Research Service Introduction

11.2.4 PPD Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.2.5 PPD Recent Development

11.3 LabCorp

11.3.1 LabCorp Company Details

11.3.2 LabCorp Business Overview

11.3.3 LabCorp Pharmacokinetic Research Service Introduction

11.3.4 LabCorp Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.3.5 LabCorp Recent Development

11.4 Charles River

11.4.1 Charles River Company Details

11.4.2 Charles River Business Overview

11.4.3 Charles River Pharmacokinetic Research Service Introduction

11.4.4 Charles River Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.4.5 Charles River Recent Development

11.5 BioPharma Services

11.5.1 BioPharma Services Company Details

11.5.2 BioPharma Services Business Overview

11.5.3 BioPharma Services Pharmacokinetic Research Service Introduction

11.5.4 BioPharma Services Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.5.5 BioPharma Services Recent Development

11.6 Biotrial

11.6.1 Biotrial Company Details

11.6.2 Biotrial Business Overview

11.6.3 Biotrial Pharmacokinetic Research Service Introduction

11.6.4 Biotrial Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.6.5 Biotrial Recent Development

11.7 QPS Holdings

11.7.1 QPS Holdings Company Details

11.7.2 QPS Holdings Business Overview

11.7.3 QPS Holdings Pharmacokinetic Research Service Introduction

11.7.4 QPS Holdings Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.7.5 QPS Holdings Recent Development

11.8 Altasciences

11.8.1 Altasciences Company Details

11.8.2 Altasciences Business Overview

11.8.3 Altasciences Pharmacokinetic Research Service Introduction

11.8.4 Altasciences Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.8.5 Altasciences Recent Development

11.9 Allucent

11.9.1 Allucent Company Details

11.9.2 Allucent Business Overview

11.9.3 Allucent Pharmacokinetic Research Service Introduction

11.9.4 Allucent Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.9.5 Allucent Recent Development

11.10 Admescope

11.10.1 Admescope Company Details

11.10.2 Admescope Business Overview

11.10.3 Admescope Pharmacokinetic Research Service Introduction

11.10.4 Admescope Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.10.5 Admescope Recent Development

11.11 CTI

11.11.1 CTI Company Details

11.11.2 CTI Business Overview

11.11.3 CTI Pharmacokinetic Research Service Introduction

11.11.4 CTI Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.11.5 CTI Recent Development

11.12 WuXi AppTec

11.12.1 WuXi AppTec Company Details

11.12.2 WuXi AppTec Business Overview

11.12.3 WuXi AppTec Pharmacokinetic Research Service Introduction

11.12.4 WuXi AppTec Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.12.5 WuXi AppTec Recent Development

11.13 GenScript

11.13.1 GenScript Company Details

11.13.2 GenScript Business Overview

11.13.3 GenScript Pharmacokinetic Research Service Introduction

11.13.4 GenScript Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.13.5 GenScript Recent Development

11.14 Wuxi Biologics

11.14.1 Wuxi Biologics Company Details

11.14.2 Wuxi Biologics Business Overview

11.14.3 Wuxi Biologics Pharmacokinetic Research Service Introduction

11.14.4 Wuxi Biologics Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.14.5 Wuxi Biologics Recent Development

11.15 Medicilon

11.15.1 Medicilon Company Details

11.15.2 Medicilon Business Overview

11.15.3 Medicilon Pharmacokinetic Research Service Introduction

11.15.4 Medicilon Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.15.5 Medicilon Recent Development

11.16 Pharmaron

11.16.1 Pharmaron Company Details

11.16.2 Pharmaron Business Overview

11.16.3 Pharmaron Pharmacokinetic Research Service Introduction

11.16.4 Pharmaron Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.16.5 Pharmaron Recent Development

11.17 Frontage

11.17.1 Frontage Company Details

11.17.2 Frontage Business Overview

11.17.3 Frontage Pharmacokinetic Research Service Introduction

11.17.4 Frontage Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.17.5 Frontage Recent Development

11.18 Shanghai Model

11.18.1 Shanghai Model Company Details

11.18.2 Shanghai Model Business Overview

11.18.3 Shanghai Model Pharmacokinetic Research Service Introduction

11.18.4 Shanghai Model Revenue in Pharmacokinetic Research Service Business (2020-2025)

11.18.5 Shanghai Model Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Pharmacokinetic Research Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vitro and Radioactive ADME
Table 3. Key Players of In Vivo PK and PD
Table 4. Key Players of New Drugs and New Molecules
Table 5. Key Players of Other
Table 6. Global Pharmacokinetic Research Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Pharmacokinetic Research Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Pharmacokinetic Research Service Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Pharmacokinetic Research Service Market Share by Region (2020-2025)
Table 10. Global Pharmacokinetic Research Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Pharmacokinetic Research Service Market Share by Region (2026-2031)
Table 12. Pharmacokinetic Research Service Market Trends
Table 13. Pharmacokinetic Research Service Market Drivers
Table 14. Pharmacokinetic Research Service Market Challenges
Table 15. Pharmacokinetic Research Service Market Restraints
Table 16. Global Pharmacokinetic Research Service Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Pharmacokinetic Research Service Market Share by Players (2020-2025)
Table 18. Global Top Pharmacokinetic Research Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Research Service as of 2024)
Table 19. Ranking of Global Top Pharmacokinetic Research Service Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pharmacokinetic Research Service Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Pharmacokinetic Research Service, Headquarters and Area Served
Table 22. Global Key Players of Pharmacokinetic Research Service, Product and Application
Table 23. Global Key Players of Pharmacokinetic Research Service, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmacokinetic Research Service Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Pharmacokinetic Research Service Revenue Market Share by Type (2020-2025)
Table 27. Global Pharmacokinetic Research Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Pharmacokinetic Research Service Revenue Market Share by Type (2026-2031)
Table 29. Global Pharmacokinetic Research Service Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmacokinetic Research Service Revenue Market Share by Application (2020-2025)
Table 31. Global Pharmacokinetic Research Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Pharmacokinetic Research Service Revenue Market Share by Application (2026-2031)
Table 33. North America Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Pharmacokinetic Research Service Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Pharmacokinetic Research Service Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Pharmacokinetic Research Service Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Pharmacokinetic Research Service Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Pharmacokinetic Research Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Pharmacokinetic Research Service Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmacokinetic Research Service Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eurofins Company Details
Table 49. Eurofins Business Overview
Table 50. Eurofins Pharmacokinetic Research Service Product
Table 51. Eurofins Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 52. Eurofins Recent Development
Table 53. PPD Company Details
Table 54. PPD Business Overview
Table 55. PPD Pharmacokinetic Research Service Product
Table 56. PPD Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 57. PPD Recent Development
Table 58. LabCorp Company Details
Table 59. LabCorp Business Overview
Table 60. LabCorp Pharmacokinetic Research Service Product
Table 61. LabCorp Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 62. LabCorp Recent Development
Table 63. Charles River Company Details
Table 64. Charles River Business Overview
Table 65. Charles River Pharmacokinetic Research Service Product
Table 66. Charles River Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 67. Charles River Recent Development
Table 68. BioPharma Services Company Details
Table 69. BioPharma Services Business Overview
Table 70. BioPharma Services Pharmacokinetic Research Service Product
Table 71. BioPharma Services Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 72. BioPharma Services Recent Development
Table 73. Biotrial Company Details
Table 74. Biotrial Business Overview
Table 75. Biotrial Pharmacokinetic Research Service Product
Table 76. Biotrial Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 77. Biotrial Recent Development
Table 78. QPS Holdings Company Details
Table 79. QPS Holdings Business Overview
Table 80. QPS Holdings Pharmacokinetic Research Service Product
Table 81. QPS Holdings Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 82. QPS Holdings Recent Development
Table 83. Altasciences Company Details
Table 84. Altasciences Business Overview
Table 85. Altasciences Pharmacokinetic Research Service Product
Table 86. Altasciences Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 87. Altasciences Recent Development
Table 88. Allucent Company Details
Table 89. Allucent Business Overview
Table 90. Allucent Pharmacokinetic Research Service Product
Table 91. Allucent Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 92. Allucent Recent Development
Table 93. Admescope Company Details
Table 94. Admescope Business Overview
Table 95. Admescope Pharmacokinetic Research Service Product
Table 96. Admescope Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 97. Admescope Recent Development
Table 98. CTI Company Details
Table 99. CTI Business Overview
Table 100. CTI Pharmacokinetic Research Service Product
Table 101. CTI Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 102. CTI Recent Development
Table 103. WuXi AppTec Company Details
Table 104. WuXi AppTec Business Overview
Table 105. WuXi AppTec Pharmacokinetic Research Service Product
Table 106. WuXi AppTec Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 107. WuXi AppTec Recent Development
Table 108. GenScript Company Details
Table 109. GenScript Business Overview
Table 110. GenScript Pharmacokinetic Research Service Product
Table 111. GenScript Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 112. GenScript Recent Development
Table 113. Wuxi Biologics Company Details
Table 114. Wuxi Biologics Business Overview
Table 115. Wuxi Biologics Pharmacokinetic Research Service Product
Table 116. Wuxi Biologics Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 117. Wuxi Biologics Recent Development
Table 118. Medicilon Company Details
Table 119. Medicilon Business Overview
Table 120. Medicilon Pharmacokinetic Research Service Product
Table 121. Medicilon Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 122. Medicilon Recent Development
Table 123. Pharmaron Company Details
Table 124. Pharmaron Business Overview
Table 125. Pharmaron Pharmacokinetic Research Service Product
Table 126. Pharmaron Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 127. Pharmaron Recent Development
Table 128. Frontage Company Details
Table 129. Frontage Business Overview
Table 130. Frontage Pharmacokinetic Research Service Product
Table 131. Frontage Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 132. Frontage Recent Development
Table 133. Shanghai Model Company Details
Table 134. Shanghai Model Business Overview
Table 135. Shanghai Model Pharmacokinetic Research Service Product
Table 136. Shanghai Model Revenue in Pharmacokinetic Research Service Business (2020-2025) & (US$ Million)
Table 137. Shanghai Model Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
muLu

List of Figures

Figure 1. Pharmacokinetic Research Service Picture
Figure 2. Global Pharmacokinetic Research Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmacokinetic Research Service Market Share by Type: 2024 VS 2031
Figure 4. In Vitro and Radioactive ADME Features
Figure 5. In Vivo PK and PD Features
Figure 6. New Drugs and New Molecules Features
Figure 7. Other Features
Figure 8. Global Pharmacokinetic Research Service Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharmacokinetic Research Service Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Industry Case Studies
Figure 11. Government and Ministry of Health Case Studies
Figure 12. Agriculture and Chemical Industry Case Studies
Figure 13. University Case Studies
Figure 14. Pharmacokinetic Research Service Report Years Considered
Figure 15. Global Pharmacokinetic Research Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Pharmacokinetic Research Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Pharmacokinetic Research Service Market Share by Region: 2024 VS 2031
Figure 18. Global Pharmacokinetic Research Service Market Share by Players in 2024
Figure 19. Global Top Pharmacokinetic Research Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Research Service as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Pharmacokinetic Research Service Revenue in 2024
Figure 21. North America Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Pharmacokinetic Research Service Market Share by Country (2020-2031)
Figure 23. United States Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Pharmacokinetic Research Service Market Share by Country (2020-2031)
Figure 27. Germany Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Pharmacokinetic Research Service Market Share by Region (2020-2031)
Figure 35. China Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Pharmacokinetic Research Service Market Share by Country (2020-2031)
Figure 43. Mexico Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Pharmacokinetic Research Service Market Share by Country (2020-2031)
Figure 47. Turkey Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Pharmacokinetic Research Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Eurofins Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 51. PPD Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 52. LabCorp Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 53. Charles River Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 54. BioPharma Services Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 55. Biotrial Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 56. QPS Holdings Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 57. Altasciences Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 58. Allucent Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 59. Admescope Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 60. CTI Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 61. WuXi AppTec Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 62. GenScript Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 63. Wuxi Biologics Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 64. Medicilon Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 65. Pharmaron Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 66. Frontage Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 67. Shanghai Model Revenue Growth Rate in Pharmacokinetic Research Service Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Pharmacokinetic Research Service market?zhanKai
The top companies in the global Pharmacokinetic Research Service market are Eurofins、PPD、LabCorp.
den_biaoTiZhungShi

Related Reports

Global Pharmacokinetic Research Service Market Research Report 2025

Industry: Service & Software

Published Date: 2025-03-11

Pages: 98 Pages

Report ld: 4638136

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Online

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now